Insulin aspart, recombinant Subcutaneous and Viramune Suspension
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Viramune Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nevirapine
Brand name: Viramune, Viramune XR
Synonyms: Viramune
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Viramune XR
- Insulin aspart, recombinant Subcutaneous-Virasal
- Insulin aspart, recombinant Subcutaneous-Virasal Topical
- Insulin aspart, recombinant Subcutaneous-Viravan P
- Insulin aspart, recombinant Subcutaneous-Viravan PDM
- Insulin aspart, recombinant Subcutaneous-Virazole
- Viramune Suspension-Insulin degludec
- Viramune Suspension-Insulin Degludec (U-100) Prefilled Pens
- Viramune Suspension-Insulin Degludec (U-100) Vials
- Viramune Suspension-Insulin Degludec (U-200) Prefilled Pens
- Viramune Suspension-Insulin degludec and liraglutide
- Viramune Suspension-Insulin degludec and liraglutide Subcutaneous